Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aimei Health Technology CoAFJK -2.38%16 Return-on-Tangible-Asset is -2.67% as of Jun. 2026. GuruFocus rates AFJK with a GF Score™ of 16/100. The stock has 2 warning signs investors should review. Among 529 Diversified Financial Services companies, Aimei Health Technology Co ranks better than 62.57% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Aimei Health Technology Co's annualizedNet Income for the quarter that ended in Jun. 2026 was $-0.33 Mil. Aimei Health Technology Co's average total tangible assets for the quarter that ended in Jun. 2026 was $12.41 Mil. Therefore, Aimei Health Technology Co's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was -2.67%.
The historical rank and industry rank for Aimei Health Technology Co's Return-on-Tangible-Asset or its related term are showing as below:
AFJK'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 1.62 Med: 3.01 Max: 3.54
Current: 1.62
During the past 3 years, Aimei Health Technology Co's highest Return-on-Tangible-Asset was 3.54%. The lowest was 1.62%. And the median was 3.01%.
AFJK's Return-on-Tangible-Asset is ranked better than 62.57% of 529
companies
in the Diversified Financial Services industry
Industry Median: 0.96
vs AFJK: 1.62
Aimei Health Technology Co (NAS:AFJK) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Aimei Health Technology Co Return-on-Tangible-Asset Related Terms
Aimei Health Technology Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aimei Health Technology Co Return-on-Tangible-Asset Chart
AFJK vs NOEM, MSSAF, DTSQ: Return-on-Tangible-Asset Comparison
For the Shell Companies subindustry, Aimei Health Technology Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aimei Health Technology Co Return-on-Tangible-Asset vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Aimei Health Technology Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Aimei Health Technology Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of -2.67% mean?
Aimei Health Technology Co (AFJK) has a Return-on-Tangible-Asset of -2.67% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aimei Health Technology Co and its competitors. Over the past decade, Aimei Health Technology Co's Return-on-Tangible-Asset has ranged from 1.62 to 3.54. According to the industry distribution chart, Aimei Health Technology Co ranks #198 out of 529 companies in the Diversified Financial Services industry, placing it in the top 37.4%.
Is Aimei Health Technology Co's Return-on-Tangible-Asset too high?
Aimei Health Technology Co's current Return-on-Tangible-Asset is -2.67%. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 3.54. Based on the distribution chart, Aimei Health Technology Co ranks #198 out of 529 companies in the Diversified Financial Services industry, which is above the industry midpoint. Overall, Aimei Health Technology Co has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Aimei Health Technology Co's Return-on-Tangible-Asset compare to NOEM and MSSAF?
According to the Diversified Financial Services industry distribution chart, Aimei Health Technology Co ranks #198 out of 529 companies for Return-on-Tangible-Asset. This puts Aimei Health Technology Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.96. Historically, Aimei Health Technology Co's own Return-on-Tangible-Asset has ranged from 1.62 to 3.54 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Diversified Financial Services company?
The median Return-on-Tangible-Asset among Diversified Financial Services companies is 0.96, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aimei Health Technology Co and its competitors. For the Diversified Financial Services industry, the median Return-on-Tangible-Asset is 0.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aimei Health Technology Co's current Return-on-Tangible-Asset is -2.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimei Health Technology Co stock overvalued right now?
Aimei Health Technology Co (AFJK) has a current Return-on-Tangible-Asset of -2.67%. The current Return-on-Tangible-Asset is -2.67%. Aimei Health Technology Co's overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Aimei Health Technology Co (AFJK), the current Return-on-Tangible-Asset is -2.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AFJK has been successfully added to your 
